中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/31053
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 29490/55136 (53%)
Visitors : 1508051      Online Users : 735
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/31053


    Title: Effect of honey and sugars on the metabolism and disposition of naringin in rabbits
    Authors: Hou, YC;Hsiu, SL;Huang, TY;Yang, CY;Tsai, SY;Chao, PDL
    Contributors: 藥學院藥學系;China Med Coll, Dept Pharm, Grad Inst Chinese Pharmaceut Sci, Taichung 404, Taiwan;China Med Coll, Dept Pharm, Taichung, Taiwan;China Med Coll, Grad Inst Pharmaceut Chem, Taichung, Taiwan
    Date: 2001
    Issue Date: 2010-09-24 18:55:32 (UTC+8)
    Publisher: GEORG THIEME VERLAG KG
    Abstract: Bu-Zhong-Yi-Qi-Tang (BZYQT), a Chinese herbal medicine, inhibited the proliferation of human hepatoma cell lines (Hep3B, HepG2 and HA22T) dose-dependently, The IC50s of BZYQT on the proliferation of Hep3B, HepG2 and HA22T were 432.5 +/- 31.8 mug/ml, 455.4 +/- 24.2 mug/ml, and 2284.3 +/- 77.2 mug/ml respectively on day 3. However, BZYQT did not significantly inhibit the proliferation of normal human hepatocytes (Chang liver, CCL-13) at the concentration under 5,000 mug/ml. Major compounds of BZYQT, including astragaloside IV, ginsenoside Rb1 and Rg1, saikosaponin a and c, and glycyrrhizin, have been identified. To investigate the key inhibitors of BZYQT, Hep3B cells were treated with BZYQT, individual major compounds of BZYQT. and mixture of major compounds in the same ratio as present in BZYQT. Significant inhibition of proliferation was detected in BZYQT and its major compounds mixture in a comparable level. Not any individual major compound examined could suppress the proliferation of Hep3B cells. This data indicated that there could be synergistic or additive effects of the ingredients in BZYQT. BrdU incorporation. cell cycle analysis and DNA fragmentation assay revealed that BZYQT suppressed the proliferation of hepatoma cells via G0/G1 cell cycle arrest and inhibition of DNA synthesis followed by apoptosis. (C) 2001 Elsevier Science Inc. All rights reserved.
    Relation: PLANTA MEDICA 67(6):538-541
    Appears in Collections:[School of Pharmacy/Master Degree Program, Ph. D program] Journal articles

    Files in This Item:

    There are no files associated with this item.



    All items in CMUR are protected by copyright, with all rights reserved.

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback